VAERS Explorer
Back to explore

Report #2851277

Received Jul 25, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
NV
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
PNC21PNEUMO (CAPVAXIVE)MERCK & CO. INC.UNKZ003579—

Symptoms (2)

No adverse eventProduct administered to patient of inappropriate age

Symptom narrative

a 2 month old was administered CAPVAXIVE; no adverse event; This spontaneous report was received from a medical assistant referring to a 2-month-old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant therapies, and drug reactions/allergies were not reported. On an unknown date, the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) Injection (lot #Z003579, expiration date: 07-Sep-2026) (168 mcg/ml) administered as prophylaxis (dose, and route of administration were not reported) (Product administered to patient of inappropriate age). No adverse effects were reported (no adverse event).

Medical history

Comments: unknown